183 related articles for article (PubMed ID: 29880816)
1. Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch.
Cheatham AM; Davis SE; Khatua AK; Popik W
Sci Rep; 2018 Jun; 8(1):8739. PubMed ID: 29880816
[TBL] [Abstract][Full Text] [Related]
2. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
5. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
7. hnRNP A1 and secondary structure coordinate alternative splicing of Mag.
Zearfoss NR; Johnson ES; Ryder SP
RNA; 2013 Jul; 19(7):948-57. PubMed ID: 23704325
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.
Vandorpe DH; Heneghan JF; Waitzman JS; McCarthy GM; Blasio A; Magraner JM; Donovan OG; Schaller LB; Shah SS; Subramanian B; Riella CV; Friedman DJ; Pollak MR; Alper SL
Pflugers Arch; 2023 Mar; 475(3):323-341. PubMed ID: 36449077
[TBL] [Abstract][Full Text] [Related]
9. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
Simard MJ; Chabot B
Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
[TBL] [Abstract][Full Text] [Related]
10. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
[TBL] [Abstract][Full Text] [Related]
11. Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing.
Qiu J; Qu R; Lin M; Xu J; Zhu Q; Zhang Z; Sun J
Biochim Biophys Acta Gene Regul Mech; 2022 Nov; 1865(8):194875. PubMed ID: 36208849
[TBL] [Abstract][Full Text] [Related]
12. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
[TBL] [Abstract][Full Text] [Related]
13. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells.
Bruun GH; Bang JMV; Christensen LL; Brøner S; Petersen USS; Guerra B; Grønning AGB; Doktor TK; Andresen BS
Nucleic Acids Res; 2018 Sep; 46(15):7938-7952. PubMed ID: 29762696
[TBL] [Abstract][Full Text] [Related]
14. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.
Wakashin H; Heymann J; Roshanravan H; Daneshpajouhnejad P; Rosenberg A; Shin MK; Hoek M; Kopp JB
BMC Nephrol; 2020 Aug; 21(1):371. PubMed ID: 32854642
[TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
[TBL] [Abstract][Full Text] [Related]
16. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Mayeda A; Helfman DM; Krainer AR
Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
[TBL] [Abstract][Full Text] [Related]
17. Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping.
Zhang B; Xie SH; Hu JY; Lei SJ; Shen LH; Liu HT; Zheng Q; Zhang ZM; Wu CL; Li Q; Wang F
Acta Pharmacol Sin; 2023 Nov; 44(11):2307-2321. PubMed ID: 37402999
[TBL] [Abstract][Full Text] [Related]
18. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
Chabot B; Blanchette M; Lapierre I; La Branche H
Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
[TBL] [Abstract][Full Text] [Related]
19. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
20. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.
Ekulu PM; Adebayo OC; Decuypere JP; Bellucci L; Elmonem MA; Nkoy AB; Mekahli D; Bussolati B; van den Heuvel LP; Arcolino FO; Levtchenko EN
Cells; 2021 Jul; 10(8):. PubMed ID: 34440683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
